R-Deprenyl: Pharmacological Spectrum of its Activity

Some puzzling pharmacological effects of monoamine oxidase inhibitors.

J. Knoll, K. Magyar · PubMed · 1972 · 562 citations

Molecular Pharmacology, Pharmacological Study, Biochemistry +8

Increased life expectancy resulting from addition of l-deprenyl to Madopar� treatment in Parkinson's disease: A longterm study

W Birkmayer, J. Knoll, Peter Riederer et al. · Journal of Neural Transmission · 1985 · 436 citations

Longevity, Parkinson Disease, Dementia +9

Mapping Human Brain Monoamine Oxidase A and B with¹¹C-Labeled Suicide Inactivators and PET

Joanna S. Fowler, Robert MacGregor, Alfred P. Wolf et al. · Science · 1987 · 393 citations

The potentiation of the anti akinetic effect after L-Dopa treatment by an inhibitor of Mao-B, deprenil

W Birkmayer, Peter Riederer, Moussa B. H. Youdim et al. · Journal of Neural Transmission · 1975 · 361 citations

Medicine, Anti Akinetic Effect, Psychopharmacology +7

IMPLICATIONS OF COMBINED TREATMENT WITH 'MADOPAR' AND L-DEPRENIL IN PARKINSON'S DISEASE

W Birkmayer, Peter Riederer, L Ambrozi et al. · The Lancet · 1977 · 294 citations

Parkinson Disease, Neuropharmacology, Progressive Supranuclear Palsy +7